Power Law company profile

ASLAN Pharmaceuticals

Biotech & Life Sciences · Singapore, Singapore · Founded 2010 · IPO 2018 Unicorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation

$339M

Market cap · 2026

Revenue

$12M

Latest reported FY

Investors

10 investors on ASLAN Pharmaceuticals's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series A 1 investor entered at this stage

Series B+ 9 investors entered at this stage

Global footprint

Web traffic by country

530 monthly visits
across markets

🇺🇸 United States94.3%

Top 1 markets shown

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo